Celmatix
1 known investors
Celmatix Therapeutics developed a discovery portfolio focused on women's health, including therapeutic programs for infertility, endometriosis, and ovarian aging. The company's pipeline included an oral FSH receptor agonist, a JNK inhibitor, and AMH-targeting antibodies.
BiotechFemTechHealthtech
Investors · 1
In the news
- MedCity FemFwd: How Celmatix is Using ARPA-H's Sprint for Women's Health Funding - MedCity Newsmedcitynews.com · 2024
- Celmatix - 2025 Company Profile, Team, Funding & Competitors - Tracxntracxn.com · 2021
- Celmatix - 2026 Funding Rounds & List of Investors - Tracxntracxn.com · 2021
- A startup that promised to use genetics to help people conceive shut down its lab and laid off employees after it failed to raise funding. In a new lawsuit, it blames 23andMe.businessinsider.com · 2019
- Fertility-prediction startup Celmatix seeks funding | PE Hubpehub.com · 2018
- Celmatix is Awarded $4.5M to Expand Footprint in New York City - BioSpacebiospace.com · 2017